FuelCell Energy Inc vs Stryker Corporation — how do they compare? FuelCell Energy Inc trades at $20.85 (market cap $1.54B), while Stryker Corporation trades at $339.96 (market cap $133.54B). The key difference: Stryker Corporation is far larger — about 86.7× FuelCell Energy Inc's market cap, and Stryker Corporation pays a 1.01% dividend while FuelCell Energy Inc pays none. Which is the better fit depends on your goals.
| FCEL | SYK | |
|---|---|---|
Market Cap | $1.54B | $133.54B |
Sector | Industrials | Technology |
52-Week High | $36.01 | $394.34 |
52-Week Low | $3.92 | $282.58 |
Enterprise Value | $1.38B | $145.01B |
Dividend Yield | — | 1.01% |
Signals from Pluang's Aura AI — not financial advice
FuelCell Energy (FCEL) trades at $19.83, down 2.94% on the day, with a bearish technical signal and negative profitability metrics. The company reported a net loss of $187.90 million on $158.16 million revenue for 2025, though it beat EPS estimates in two recent quarters. Recent news highlights partnerships with Siemens and AI-driven power demand opportunities, contributing to volatile stock performance.
Outlook remains speculative with high risk due to persistent losses and negative margins, offset by analyst optimism (45% buy rating) and a $20.75 consensus price target. Key risks include cash burn, competitive pressures, and execution challenges in scaling hydrogen technology.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →